Work

Development of pemphigus vulgaris after the second dose of the mRNA‐1273 SARS‐Cov‐2 vaccine

Year: 2021

Type: article

Study design: Case Report

Source: Oral Diseases

DOI: 10.1111/odi.14089

Authors: Ioannis G. Koutlas, Renee Camara, Prokopios P. Argyris, Mark Denis P. Davis, Daniel D. Miller

Institutions: University of Minnesota, University of Minnesota System, Howard Hughes Medical Institute, Masonic Cancer Center, Mayo Clinic

Language: English

Topic: Autoimmune Bullous Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3215007366

FWCI: 5.639

Cites: 8

Cited by: 25

Related to: 10